Sort   by:  
 Page size 
UnknownSymptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom.
Not available
S-EPMC8767848 | biostudies-literature
UnknownTracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom.
Not available
S-EPMC8693687 | biostudies-literature
UnknownCOVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK.
Not available
S-EPMC10209557 | biostudies-literature
UnknownAntibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.
Not available
S-EPMC8294260 | biostudies-literature
UnknownRisk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population.
Not available
S-EPMC10837445 | biostudies-literature
UnknownAntibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines.
Not available
S-EPMC9117148 | biostudies-literature
UnknownSARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.
Not available
S-EPMC9243074 | biostudies-literature
UnknownCommunity prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey.
Not available
S-EPMC7786000 | biostudies-literature
UnknownAccurate whole human genome sequencing using reversible terminator chemistry.
Not available
S-EPMC2581791 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
Sort   by:  
 Page size